pmc logo imageJournal ListSearchpmc logo image
Logo of cmajCMAJ home pageCMAJ information for authors page


PubMed articles by:

CMAJ. 1993 April 1; 148(7): 1155–1160.

Are worry-free transfusions just a whiff of ozone away?

A C Baggs

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or see the PubMed citation or the full text of some References or click on a page below to browse page by page.

This list contains those references that cite another article in PMC or have a citation in PubMed. It may not include all the original references for this article.
  • Anderson RM, May RM. Understanding the AIDS pandemic. Sci Am. 1992 May;266(5):58-61–64-6. [PubMed]
  • Garber GE, Cameron DW, Hawley-Foss N, Greenway D, Shannon ME. The use of ozone-treated blood in the therapy of HIV infection and immune disease: a pilot study of safety and efficacy. AIDS. 1991 Aug;5(8):981–984. [PubMed]
  • Wells KH, Latino J, Gavalchin J, Poiesz BJ. Inactivation of human immunodeficiency virus type 1 by ozone in vitro. Blood. 1991 Oct 1;78(7):1882–1890. [PubMed]
  • Carpendale MT, Freeberg JK. Ozone inactivates HIV at noncytotoxic concentrations. Antiviral Res. 1991 Oct;16(3):281–292. [PubMed]
  • Staal FJ, Ela SW, Roederer M, Anderson MT, Herzenberg LA, Herzenberg LA. Glutathione deficiency and human immunodeficiency virus infection. Lancet. 1992 Apr 11;339(8798):909–912. [PubMed]
  • McBride TJ, Preston BD, Loeb LA. Mutagenic spectrum resulting from DNA damage by oxygen radicals. Biochemistry. 1991 Jan 8;30(1):207–213. [PubMed]
  • Surgenor DM, Wallace EL, Hao SH, Chapman RH. Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med. 1990 Jun 7;322(23):1646–1651. [PubMed]
  • Busch MP, Eble BE, Khayam-Bashi H, Heilbron D, Murphy EL, Kwok S, Sninsky J, Perkins HA, Vyas GN. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med. 1991 Jul 4;325(1):1–5. [PubMed]
  • Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TR, Bottenfield S, Conley LJ, Kohlenberg SH, Castro KG, Dahan BA, Schable CA, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med. 1992 Mar 12;326(11):726–732. [PubMed]
  • Ward JW, Holmberg SD, Allen JR, Cohn DL, Critchley SE, Kleinman SH, Lenes BA, Ravenholt O, Davis JR, Quinn MG, et al. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N Engl J Med. 1988 Feb 25;318(8):473–478. [PubMed]
  • Eisenstein BI. The polymerase chain reaction. A new method of using molecular genetics for medical diagnosis. N Engl J Med. 1990 Jan 18;322(3):178–183. [PubMed]
  • Mullis KB. The unusual origin of the polymerase chain reaction. Sci Am. 1990 Apr;262(4):56-61–64-5. [PubMed]
  • Persing DH. Polymerase chain reaction: trenches to benches. J Clin Microbiol. 1991 Jul;29(7):1281–1285. [PubMed]
  • Weitberg AB, Weitzman SA, Destrempes M, Latt SA, Stossel TP. Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N Engl J Med. 1983 Jan 6;308(1):26–30. [PubMed]
  • Niki E. Lipid antioxidants: how they may act in biological systems. Br J Cancer Suppl. 1987 Jun;8:153–157. [PubMed]
  • Shatos MA, Doherty JM, Orfeo T, Hoak JC, Collen D, Stump DC. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals. J Biol Chem. 1992 Jan 5;267(1):597–601. [PubMed]
  • Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 1988 Nov 29;27(24):8706–8711. [PubMed]
  • Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984 Apr 1;219(1):1–14. [PubMed]
  • Giunta S, Galeazzi L, Groppa G. 'Oxygen toxicity' induced by isoproterenol oxidation on living cells. An in vitro prokaryotic model. Arch Gerontol Geriatr. 1990 10(2):207–216.Mar–Apr; [PubMed]
  • Rubanyi GM. Vascular effects of oxygen-derived free radicals. Free Radic Biol Med. 1988;4(2):107–120. [PubMed]
  • Turrens JF. The potential of antioxidant enzymes as pharmacological agents in vivo. Xenobiotica. 1991 Aug;21(8):1033–1040. [PubMed]
  • LeBel CP, Bondy SC. Oxygen radicals: common mediators of neurotoxicity. Neurotoxicol Teratol. 1991 13(3):341–346.May–Jun; [PubMed]
  • Halliwell B. Production of superoxide, hydrogen peroxide and hydroxyl radicals by phagocytic cells: a cause of chronic inflammatory disease? Cell Biol Int Rep. 1982 Jun;6(6):529–542. [PubMed]
  • Phillips BJ, Anderson D, Gangolli SD. Influence of phagocyte-derived active oxygen species in tissue responses to tumour promoters and irritants. Food Chem Toxicol. 1986 24(6-7):681–683.Jun–Jul; [PubMed]
  • Suthanthiran M, Solomon SD, Williams PS, Rubin AL, Novogrodsky A, Stenzel KH. Hydroxyl radical scavengers inhibit human natural killer cell activity. Nature. 307(5948):276–278. [PubMed]
  • Chaudhri G, Hunt NH, Clark IA, Ceredig R. Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. Cell Immunol. 1988 Aug;115(1):204–213. [PubMed]
  • Faden H, Kaul TN, Ogra PL. Activation of oxidative and arachidonic acid metabolism in neutrophils by respiratory syncytial virus antibody complexes: possible role in disease. J Infect Dis. 1983 Jul;148(1):110–116. [PubMed]
  • Doelman CJ, Bast A. Oxygen radicals in lung pathology. Free Radic Biol Med. 1990;9(5):381–400. [PubMed]
  • Ward PA, Till GO, Hatherill JR, Annesley TM, Kunkel RG. Systemic complement activation, lung injury, and products of lipid peroxidation. J Clin Invest. 1985 Aug;76(2):517–527. [PubMed]
  • Lifson JD, Reyes GR, McGrath MS, Stein BS, Engleman EG. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science. 1986 May 30;232(4754):1123–1127. [PubMed]
  • Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991 Aug;10(8):2247–2258. [PubMed]
  • Haseltine WA, Wong-Staal F. The molecular biology of the AIDS virus. Sci Am. 1988 Oct;259(4):52–62. [PubMed]
  • Wallace BM, Lasker JS. Awakenings ... UV light and HIV gene activation. Science. 1992 Aug 28;257(5074):1211–1212. [PubMed]
  • Stellrecht KA, Sperber K, Pogo BG. Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus. J Virol. 1992 Apr;66(4):2051–2056. [PubMed]
  • Ensoli B, Lusso P, Schachter F, Josephs SF, Rappaport J, Negro F, Gallo RC, Wong-Staal F. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J. 1989 Oct;8(10):3019–3027. [PubMed]
  • Archer DL. Food counseling should be given to all persons infected with the human immunodeficiency virus. J Infect Dis. 1990 Feb;161(2):358–359. [PubMed]
  • Clark IA, Hunt NH. Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun. 1983 Jan;39(1):1–6. [PubMed]
  • Bocci V, Paulesu L. Studies on the biological effects of ozone 1. Induction of interferon gamma on human leucocytes. Haematologica. 1990 75(6):510–515.Nov–Dec; [PubMed]
  • McDonald JA, Caruso L, Karayiannis P, Scully LJ, Harris JR, Forster GE, Thomas HC. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon. Hepatology. 1987 7(4):719–723.Jul–Aug; [PubMed]